People · Operator
Named in public records as an officer, director or promoter · active 2016–2023 · Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| 6K Inc. | — | Other Technology | Series D+ | $217.7M | $932.4M | 2020 |
| Venn Biosciences Corp | — | Biotechnology | Series D+ | $214.6M | $5.0B | 2020 |
| Niron Magnetics, Inc. | — | Other Technology | Series C | $106.0M | $995.3M | 2023 |
| Nuburu, Inc. | — | Other Technology | Series B | $64.8M | $104.0M | 2016 |
| Voltaiq, Inc. | — | Other Technology | Series A | $10.4M | $43.1M | 2018 |
| TeraPore Technologies, Inc. | — | Biotechnology | Seed | $3.5M | $78.8M | 2017 |
David Michael at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Michael on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Seldin | 4 | 11 |
| Adam D'Augelli | 1 | 13 |
| Amit Shah | 1 | 10 |
| Konstantine Drakonakis | 1 | 8 |
| Adam Sharkawy | 1 | 8 |
| William McCullen | 1 | 7 |
| Jenny Rooke | 1 | 5 |
| Mark Little | 1 | 5 |
| Michael Berolzheimer | 1 | 4 |
| Thomas Wilson | 1 | 4 |
| Aaron Bent | 1 | 3 |
| Bill McCullen | 1 | 3 |
| David M. Seldin | 1 | 3 |
| Mark Mills | 1 | 3 |
| Kedar Gupta | 1 | 3 |
| Jimmy Kan | 1 | 2 |
| Francis Thibodeau | 1 | 2 |
| Jeffrey Chamberlain | 1 | 2 |
| Aldo Carrascoso | 1 | 2 |
| Brian Knaley | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.